Cartesian Therapeutics, Inc. Prepaid Expense and Other Assets, Noncurrent
Cartesian Therapeutics, Inc. (RNAC) had Prepaid Expense and Other Assets, Noncurrent of $4.78 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › and Other Assets
us-gaap:PrepaidExpenseAndOtherAssetsNoncurrent · last filed 2026-08-06
- 2026-06-30: Prepaid Expense and Other Assets, Noncurrent $4.78M.
- 2026-03-31: Prepaid Expense and Other Assets, Noncurrent $5.55M.
- 2025-12-31: Prepaid Expense and Other Assets, Noncurrent $5.55M.
- 2025-09-30: Prepaid Expense and Other Assets, Noncurrent $5.55M.
| Period end | Prepaid Expense and Other Assets, Noncurrent |
|---|---|
| 2026-06-30 | $4.78M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $5.55M 10-Q · filed 2026-04-30 |
| 2025-12-31 | $5.55M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $5.55M 10-Q · filed 2025-11-06 |
| 2024-12-31 | $518.00K 10-K · filed 2026-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |